Reva Basho
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- COVID-19 and healthcare impacts
- HER2/EGFR in Cancer Research
-
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
Papers in
- Oncology 29
- Cancer Immunotherapy and Biomarkers 16
- Cancer Treatment and Pharmacology 10
- HER2/EGFR in Cancer Research 9
-
- Breast Cancer Treatment Studies 9
- Cancer Genomics and Diagnostics 6
- Co-authors
- Cuiwei Liu (2 shared papers)Xiaojiang Cui (2 shared papers)Yanxia Zhao (1 shared paper)Derick Okwan‐Duodu (1 shared paper)Rashmi K. Murthy (2 shared papers)Daniel D. Karp (2 shared papers)Razelle Kurzrock (3 shared papers)Thorunn Helgason (3 shared papers)
- Journals
- Journal of Clinical Oncology (15 papers)Cancer Research (7 papers)Frontiers in Oncology (2 papers)Annals of Oncology (2 papers)Current Oncology Reports (1 paper)
- Partner nations
- United StatesSpainUnited Kingdom
In The Last Decade
Reva Basho
32 papers receiving 508 citations
Peers
Comparison fields: 5 of 73
- Oncology 316
- Cancer Research 144
- Dermatology 34
- Pulmonary and Respiratory Medicine 112
- Infectious Diseases 61
Countries citing papers authored by Reva Basho
This map shows the geographic impact of Reva Basho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Reva Basho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Reva Basho more than expected).
Fields of papers citing papers by Reva Basho
This network shows the impact of papers produced by Reva Basho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Reva Basho. The network helps show where Reva Basho may publish in the future.
Co-authors
The 25 scholars most cited alongside Reva Basho, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 152 | |
| 2 | 2020 | 131 | |
| 3 | 2018 | 45 | |
| 4 | 2019 | 26 | |
| 5 | 2019 | 18 | |
| 6 | 2022 | 17 | |
| 7 | 2021 | 14 | |
| 8 | 2022 | 14 | |
| 9 | 2023 | 10 | |
| 10 | Clinical Applications and Limitations of Next-Generation Sequencing | 2015 | 10 |
| 11 | 2022 | 10 | |
| 12 | 2018 | 9 | |
| 13 | 2019 | 8 | |
| 14 | 2024 | 6 | |
| 15 | 2020 | 5 | |
| 16 | 2021 | 5 | |
| 17 | 2020 | 4 | |
| 18 | 2024 | 4 | |
| 19 | 2023 | 3 | |
| 20 | 2022 | 3 |
About Reva Basho
Reva Basho is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Molecular Biology and Radiology, Nuclear Medicine and Imaging, having authored 35 papers that have together received 514 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (16 papers), Cancer Treatment and Pharmacology (10 papers), Breast Cancer Treatment Studies (9 papers), HER2/EGFR in Cancer Research (9 papers), Advanced Breast Cancer Therapies (8 papers), Cancer Genomics and Diagnostics (6 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Cancer Research and Treatments (3 papers). The work is most often cited by research in Oncology (316 citations), Cancer Research (144 citations), Dermatology (34 citations), Pulmonary and Respiratory Medicine (112 citations) and Infectious Diseases (61 citations). Reva Basho has collaborated with scholars based in United States, Spain and United Kingdom. Frequent co-authors include Cuiwei Liu, Xiaojiang Cui, Yanxia Zhao, Derick Okwan‐Duodu, Rashmi K. Murthy, Daniel D. Karp, Razelle Kurzrock, Thorunn Helgason, Kenneth R. Hess and Funda Meric‐Bernstam. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Frontiers in Oncology, Annals of Oncology and Current Oncology Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.